Stock Track | Thermo Fisher Scientific Soars 8.97% in Pre-Market After Q2 Earnings Beat and Raised Guidance

Stock Track

Jul 23

Thermo Fisher Scientific (TMO) shares surged 8.97% in pre-market trading on Thursday, following the release of second-quarter results that handily beat Wall Street expectations and an upward revision to the company's full-year 2026 outlook.

The life sciences giant reported adjusted earnings per share of $6.03, well above the analyst consensus estimate of $5.71. Revenue climbed 10% year-over-year to $11.99 billion, also exceeding the $11.70 billion forecast. The strong performance was fueled by improving customer demand across all business segments, with the laboratory products and biopharma services unit posting a near 12% revenue increase to $6.69 billion and the life-sciences solutions segment growing approximately 13% to $2.82 billion.

Management further boosted investor confidence by raising its 2026 revenue guidance to a range of $47.4 billion to $48.1 billion and lifting its adjusted EPS forecast to $24.93-$25.33. The company also projected third-quarter adjusted EPS to be 35 to 40 cents higher than the second-quarter figure, signaling sustained momentum. The earnings beat and upbeat guidance helped the stock recover from a sector-wide selloff earlier in the week, when peer Danaher's weaker outlook had dragged down life sciences tool makers.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1184850463"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184850463\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184850463?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-23 21:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184850463","market":"hk","top_or_hot":-1,"title":"Stock Track | Thermo Fisher Scientific Soars 8.97% in Pre-Market After Q2 Earnings Beat and Raised Guidance","media":"Stock Track","content":"<p>Thermo Fisher Scientific (TMO) shares surged 8.97% in pre-market trading on Thursday, following the release of second-quarter results that handily beat Wall Street expectations and an upward revision to the company's full-year 2026 outlook.</p><p>The life sciences giant reported adjusted earnings per share of $6.03, well above the analyst consensus estimate of $5.71. Revenue climbed 10% year-over-year to $11.99 billion, also exceeding the $11.70 billion forecast. The strong performance was fueled by improving customer demand across all business segments, with the laboratory products and biopharma services unit posting a near 12% revenue increase to $6.69 billion and the life-sciences solutions segment growing approximately 13% to $2.82 billion.</p><p>Management further boosted investor confidence by raising its 2026 revenue guidance to a range of $47.4 billion to $48.1 billion and lifting its adjusted EPS forecast to $24.93-$25.33. The company also projected third-quarter adjusted EPS to be 35 to 40 cents higher than the second-quarter figure, signaling sustained momentum. The earnings beat and upbeat guidance helped the stock recover from a sector-wide selloff earlier in the week, when peer Danaher's weaker outlook had dragged down life sciences tool makers.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Thermo Fisher Scientific Soars 8.97% in Pre-Market After Q2 Earnings Beat and Raised Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Thermo Fisher Scientific Soars 8.97% in Pre-Market After Q2 Earnings Beat and Raised Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-23 21:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Thermo Fisher Scientific (TMO) shares surged 8.97% in pre-market trading on Thursday, following the release of second-quarter results that handily beat Wall Street expectations and an upward revision to the company's full-year 2026 outlook.</p><p>The life sciences giant reported adjusted earnings per share of $6.03, well above the analyst consensus estimate of $5.71. Revenue climbed 10% year-over-year to $11.99 billion, also exceeding the $11.70 billion forecast. The strong performance was fueled by improving customer demand across all business segments, with the laboratory products and biopharma services unit posting a near 12% revenue increase to $6.69 billion and the life-sciences solutions segment growing approximately 13% to $2.82 billion.</p><p>Management further boosted investor confidence by raising its 2026 revenue guidance to a range of $47.4 billion to $48.1 billion and lifting its adjusted EPS forecast to $24.93-$25.33. The company also projected third-quarter adjusted EPS to be 35 to 40 cents higher than the second-quarter figure, signaling sustained momentum. The earnings beat and upbeat guidance helped the stock recover from a sector-wide selloff earlier in the week, when peer Danaher's weaker outlook had dragged down life sciences tool makers.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TMO","symbol_name":"赛默飞世尔","start_time":0,"source_url":"","article_id":"1184850463","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184850463","pubTimestamp":1784813657,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Thermo Fisher Scientific (TMO) shares surged 8.97% in pre-market trading on Thursday, following the release of second-quarter results that handily beat Wall Street expectations and an upward revision...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TMO":"赛默飞世尔"},"translate_title":"股票跟踪 | Thermo Fisher Scientific 第二季度盈利超出预期并上调指引后盘前飙升 8.97%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMO":1},"content_text":"Thermo Fisher Scientific (TMO) shares surged 8.97% in pre-market trading on Thursday, following the release of second-quarter results that handily beat Wall Street expectations and an upward revision to the company's full-year 2026 outlook.The life sciences giant reported adjusted earnings per share of $6.03, well above the analyst consensus estimate of $5.71. Revenue climbed 10% year-over-year to $11.99 billion, also exceeding the $11.70 billion forecast. The strong performance was fueled by improving customer demand across all business segments, with the laboratory products and biopharma services unit posting a near 12% revenue increase to $6.69 billion and the life-sciences solutions segment growing approximately 13% to $2.82 billion.Management further boosted investor confidence by raising its 2026 revenue guidance to a range of $47.4 billion to $48.1 billion and lifting its adjusted EPS forecast to $24.93-$25.33. The company also projected third-quarter adjusted EPS to be 35 to 40 cents higher than the second-quarter figure, signaling sustained momentum. The earnings beat and upbeat guidance helped the stock recover from a sector-wide selloff earlier in the week, when peer Danaher's weaker outlook had dragged down life sciences tool makers.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}